Neos Therapeutics (NEOS) Reports Q2 Loss of $1.65/Share

August 11, 2016 7:06 AM EDT
Get Alerts NEOS Hot Sheet
Trade NEOS Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Neos Therapeutics (NASDAQ: NEOS) reported Q2 EPS of ($1.65), versus ($7.76) reported last year. Revenue for the quarter came in at $1.49 million, versus $1.48 million reported last year.

For earnings history and earnings-related data on Neos Therapeutics (NEOS) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment